Skip to main content
. 2022 May 16;54(1):1385–1394. doi: 10.1080/07853890.2022.2075559

Table 2.

The association between smoking status and HbA1c reduction was estimated by generalised estimating equations after propensity score matching.

Model 1: dichotomous smoking status
Model 2: four groups of smoking status
Variables β (95% CI) p-value Variables β (95% CI) p-value
Group:     Group:    
Non-smokers 0   Smoking (−/−) 0  
Smokers −0.11 (−0.37, 0.16) .44 Smoking (−/+) −0.10 (−0.68, 0.47) .72
      Smoking (+/−) −0.15 (−0.60, 0.31) .52
      Smoking (+/+) −0.11 (−0.40, 0.18) .45
Time: Baseline 0   Time: Baseline 0  
3 months −2.60 (−2.81, −2.40) <.001 3 months −2.62 (−2.85, −2.40) <.001
6 months −2.73 (−2.94, −2.52) <.001 6 months −2.74 (−2.96, −2.51) <.001
9 months −2.63 (−2.84, −2.42) <.001 9 months −2.64 (−2.87, −2.42) <.001
12 months −2.68 (−2.88, −2.47) <.001 12 months −2.70 (−2.92, −2.47) <.001
Interaction of smoking group and time Interaction of smoking group and time
Baseline 0   Smoking (−/+): Baseline 0  
3 months 0.33 (0.05, 0.62) .02 3 months 0.12 (−0.46, 0.69) .68
6 months 0.31 (0.02, 0.59) .04 6 months 0.07 (−0.54, 0.69) .81
9 months 0.25 (−0.04, 0.54) .09 9 months 0.07 (−0.57, 0.71) .84
12 months 0.30 (0.01, 0.59) .04 12 months 0.18 (−0.44, 0.79) .58
      Smoking (+/−): Baseline 0  
      3 months 0.62 (0.12, 1.12) .02
      6 months 0.58 (0.06, 1.10) .03
      9 months 0.47 (−0.04, 0.99) .07
      12 months 0.48 (−0.02, 0.98) .06
      Smoking (+/+): Baseline 0  
      3 months 0.29 (−0.03, 0.60) .08
      6 months 0.25 (−0.06, 0.57) .12
      9 months 0.21 (−0.10, 0.52) .19
      12 months 0.29 (−0.02, 0.60) .07

Note. The difference in HbA1c reduction between smokers and non-smokers was estimated by the regression coefficient (β) and 95% confidence interval (95% CI) of smoking status-by-time interaction at each time point. The models were established using the backward elimination method to select control variables, including a family history of diabetes, alcohol drinking, knowledge regarding glycemic control, medication adherence, anti-hypertensive agents, blood pressure, total cholesterol, estimated glomerular filtration rate, and body weight change.

Abbreviation: HbA1c: haemoglobin A1c.